title: [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
abstract: Interferon is becoming the most important therapy for chronic hepatitis due to hepatitis C virus. Secondary effects are frequent and sometimes so important to stop the therapy. Autoimmune disorders, specially autoimmune thyroid diseases may occur. We report two out of 69 chronic hepatitis C patients treated with interferon who developed hypothyroidism, that required definitive substitutive therapy.
authors.affiliation: Servicio de Aparato Digestivo, Hospital Miguel Servet, Zaragoza.
authors.forename: F
authors.initials: F
authors.lastname: Gomollón García
authors.forename: M A
authors.initials: MA
authors.lastname: Simón Marco
authors.forename: J
authors.initials: J
authors.lastname: Vela
authors.forename: S
authors.initials: S
authors.lastname: García López
authors.forename: J
authors.initials: J
authors.lastname: Fuentes Olmo
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D007037:Hypothyroidism / Q000209:etiology*; D016898:Interferon-alpha / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha